Medpace Holdings Inc vs Tempus AI — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while Tempus AI trades at $49.05 (market cap $8.69B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| MEDP | TEM | |
|---|---|---|
Market Cap | $15.08B | $8.69B |
Sector | Technology | Broad Market / Factor |
52-Week High | $620.59 | $103.25 |
52-Week Low | $308.88 | $42.37 |
Enterprise Value | $14.55B | $9.37B |
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →